ferric pyrophosphate has been researched along with losartan potassium in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kambayashi, J; Kawasaki, T; Mori, T; Sakon, M; Shiba, E; Tsuji, Y | 1 |
Amin, NB; Anandan, JV; Besarab, A; Divine, GW; Gupta, A; Vogel, SE; Yee, J | 1 |
2 trial(s) available for ferric pyrophosphate and losartan potassium
Article | Year |
---|---|
Effect of recombinant human erythropoietin on anaemia after gastrectomy: a pilot study.
Topics: Adult; Aged; Anemia; Blood Cell Count; Diphosphates; Erythropoietin; Female; Gastrectomy; Hematocrit; Hemoglobins; Humans; Iron; Male; Middle Aged; Pilot Projects; Postoperative Care; Postoperative Complications; Preoperative Care; Recombinant Proteins; Stomach Neoplasms; Time Factors | 1995 |
Dialysate iron therapy: infusion of soluble ferric pyrophosphate via the dialysate during hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Dialysis Solutions; Diphosphates; Drug Administration Routes; Erythropoietin; Female; Ferritins; Hemoglobins; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Solubility; Transferrin | 1999 |